ANGOAngioDynamics, Inc.
What is the market doing?
No clear lean: rangebound and moderately shorted.
Rangebound, no clear trend. Oversold (RSI 29). Price is −0% vs its 200-day average.
Moderately shorted, settled Sep 30, 2026, a few days of normal trading to cover.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ANGO is trading
AngioDynamics, Inc. is +1.9% over the past year while the S&P 500 is +16%: 14 points behind the market.
1-year return · S&P 500 +16%
- vs 200-day average
- −0.47%
vs 200-day average · below trend, but not far
- RSI (14)
- 29
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 23%
Below its 52-week high
Details›
- Last close2026-10-23
- $12.37
- 1 monthS&P 500 −0.94%
- −19%
- 1 yearS&P 500 +16%
- +1.9%
- 5 yearsS&P 500 +86%
- −55%
- vs 50-day average$14.55
- −15%
- 52-week high
- $16.12
- 52-week low
- $9.70
- Annualised volatility
- 57%
| Year | Return |
|---|---|
| 2026 (year to date) | −3.7% |
| 2025 | +40% |
| 2024 | +17% |
| 2023 | −43% |
| 2022 | −50% |
| 2021 | +80% |
| 2020 | −4.2% |
| 2019 | −20% |
| 2018 | +21% |
| 2017 | −1.4% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | −3.3% |
| Feb | 10 | 5 of 10 | −1.5% |
| Mar | 10 | 6 of 10 | −0.11% |
| Apr | 10 | 2 of 10 | −3.3% |
| May | 10 | 5 of 10 | +2.1% |
| Jun | 10 | 6 of 10 | +5.0% |
| Jul | 11 | 6 of 11 | +2.4% |
| Aug | 11 | 6 of 11 | +2.8% |
| Sep | 11 | 6 of 11 | +1.5% |
| Oct | 11 | 2 of 11 | −9.9% |
| Nov | 10 | 8 of 10 | +4.1% |
| Dec | 10 | 8 of 10 | +7.5% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.
Medical Instruments & Supplies
Ranks #19 of 20 by RyuScore